Donna J. Edmonds

Alere, Inc. engages in developing, manufacturing, and marketing consumer and professional medical diagnostic products. It operates through the following segments: Professional Diagnostics, Consumer Diagnostics, and Other Non-Reportable. The Professional Diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests. The Consumer Diagnostics segment consists of manufacturing operations. The Other Non-Reportable segment includes Alere Home Monitoring, which distributes PT and INR coagulation; monitors and facilitates the distribution of equipment; and supplies to power and control customers' implanted ventricular assist devices and VADs. It also provides telemonitoring services that allow VAD coordinators to monitor patients soon after discharge and receive alerts when critical patient values fall outside pre-established ranges. The company was founded by Ronald Zwanziger on May 11, 2001 and is headquartered in Abbott Park, IL.

Ischemia Technologies, Inc. develops, manufactures and markets vitro diagnostic products with a focus on cardiovascular and acute care medicine. The Company was acquired by Inverness Medical Innovations, Inc. in March 2005. The company is headquartered in Denver, CO.

BioVentures Investors (BioVentures) is a venture capital firm founded in 1997 by Peter J. Feinstein and Marc E. Goldberg. The firm is headquartered in Wellesley, Massachusetts.

Embark Healthcare (Embark Healthcare) is a ventures capital firm founded in 2001 by David M Geliebter. The firm is headquartered in New York.

BioProtect Ltd. designs, develops and commercializes balloon systems. Its patented technology allows for the design and manufacture of implantable biodegradable balloon products that support a wide range of clinical applications in oncology and surgery. The company’s balloon implant, indicated for prostate cancer patients. BioProtect was founded by Shaul Shohat, Adrian Paz and Abraham Domb in 2004 and is headquartered in Kfar Saba, Israel.

NeatStitch Ltd. develops and manufactures medical devices. It offers NeatClose, a patented Nitinol based automatic suturing product primarily targeting the Laparoscopic Port Closure Market. The firm’s product is FDA approved and employs a simple-intuitive blunt end design therefore avoiding exposed needles and improving the safety and speed of the closure for each procedure. The company was founded in 2004 by Assaf Dekel and is headquartered in Or Akiva, Israel.

Virginia Life Science Investments LLC invests in off-shore life science companies. Its portfolio is primarily focused on companies that specialize in medical devices and diagnostics and range from simple devices through platform technologies. The company was founded on April 2, 2009 and is headquartered in Richmond, VA.

Cardiovascular Group provides cardiovascular services.

Vital Sensors Holding Co., Inc. Develops chip based pressure sensors. It offers continuous or on demand data capture and read out capabilities that will support clinicians and patients in the management of cardiovascular and other disease state. The company was founded in 2002 by Volker Bödecker and Max Georg Ostermeier and is headquartered in Richmond, VA.